ArticleEuropean radiology2015
Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.
Article in European radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Hydrophilic Polymers Enable Gastrointestinal Transit Monitoring by Fluorine-19 Magnetic Resonance Imaging.Advanced healthcare materials · 2026Article
- Stimuli-Responsive Partially Fluorinated Polymers asACS omega · 2025Review
- Polymeric (Poly(lactic-ACS omega · 2025Article
- Feasibility and optimization ofPhysics in medicine and biology · 2024Article
- Review
- Nanotechnology as a Versatile Tool forPharmaceutics · 2022Review
- Dynamic Nuclear Polarization of Silicon Carbide Micro- and Nanoparticles.ACS applied materials & interfaces · 2021Article
- Longitudinal In Vivo Assessment of Host-Microbe Interactions in a Murine Model of Pulmonary Aspergillosis.iScience · 2019Article
- Challenges for labeling and longitudinal tracking of adoptively transferred autoreactive T lymphocytes in an experimental type-1 diabetes model.Magma (New York, N.Y.) · 2019Article
- A Trimodal Imaging Platform for Tracking Viable Transplanted Pancreatic Islets In Vivo: F-19 MR, Fluorescence, and Bioluminescence Imaging.Molecular imaging and biology · 2019Article
- Low-molecular-weight paramagneticMagma (New York, N.Y.) · 2019Article
- Hydrophilic fluorinated molecules for spectralScientific reports · 2018Article
- Design of triphasic poly(lactic-RSC advances · 2018Article
- A Hyperfluorinated Hydrophilic Molecule for AqueousContrast media & molecular imaging · 2018Article
- Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.International journal of molecular sciences · 2017Review
- Pre-Microporation Improves Outcome of Pancreatic Islet Labelling for Optical andBiological procedures online · 2017Article
- Nanoparticles and clinically applicable cell tracking.The British journal of radiology · 2015Review
- Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label.PloS one · 2015Article
- Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.ACS chemical neuroscience · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
(19)F MRI is emerging as a new imaging technique for cell tracking. It is particularly attractive because of its potential for direct and precise cell quantification. The most important challenge towards in vivo applications is the sensitivity of the technique, i.e. the detection limit in a reasonable imaging time. Optimal sensitivity can be achieved with dedicated (19)F compounds together with specifically adapted hardware and acquisition methods. In this paper we introduce the (19)F MRI technique focusing on these key sensitivity issues and review the state-of-the-art of (19)F MRI and developments towards its clinical use. We calculate (19)F detection limits reported in preclinical cell and clinical (19)F drug studies in terms of tissue concentration in a 1 cm(3) voxel, as an alternate way to compare detection limits. We estimate that a tissue concentration of a few millimoles per litre (mM) of (19)F is required for a human study at a resolution of 1 cm(3).
Indexed as
Identifiers
25373770What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.